Underwater Resection of Non-pedunculated Colorectal Lesions
- Conditions
- Colorectal Neoplasms
- Interventions
- Procedure: Underwater resectionProcedure: Conventional (gas distended colon) resectionProcedure: Standard polypectomy
- Registration Number
- NCT02889679
- Lead Sponsor
- VA Northern California Health Care System
- Brief Summary
The aim of this study is to compare the efficacy of underwater resection (polypectomy) versus conventional polypectomy techniques for small and large colorectal lesions identified during colonoscopy.
- Detailed Description
Conventional endoscopic resection of small and large (≥1cm) colorectal lesions is well established and performed with the colon fully distended with gas. Conventional polypectomy is effective, but the rate of incomplete resection is approximately 10%. Incomplete eradication of precancerous lesions contributes to interval colorectal cancer; therefore, alternative techniques for resection that safely and effectively increase the rate of complete resection are important. Underwater resection (UR) of benign colorectal lesions is a novel technique that utilizes the advantages of water aided endoscopic methods and may decrease the incomplete resection rate of small and large non-pedunculated lesions.
The investigators propose the hypothesis that small (6-9mm) and large (≥1cm) non-pedunculated neoplastic colorectal lesions resected by UR (partially distended, water filled lumen without submucosal fluid injection), will significantly decrease the incomplete resection rate (IRR) compared to conventional polypectomy performed in a gas distended lumen.
Small (6-9mm) and large (≥1cm) non-pedunculated benign neoplastic colorectal lesions identified during screening, surveillance, diagnostic or therapeutic colonoscopy will be randomized to conventional polypectomy (in a gas distended lumen with or without submucosal fluid injection) versus UR (partially distended, water filled lumen without submucosal injection) at the patient level. Small (6-9mm) lesions will be removed with a 9mm firm, thin wire cold snare and large (≥1cm) lesions will be removed by snare electrocautery. Efforts to remove lesions en bloc with a small rim of normal mucosa will be made, although some larger lesions (≥2cm) may require piecemeal resection. Submucosal fluid injection with a solution may be used with conventional techniques for large and/or flat lesions. Post-polypectomy incomplete resection rates will be assessed from 4 quadrant biopsies obtained around the resection site immediately post-resection.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
- Adult (≥18 years old) male and female patients.
- Scheduled for outpatient colonoscopy.
- Patient able to provide informed consent.
- Benign, small (6-9mm) and large (≥1cm) non-pedunculated colorectal lesions.
- Diminutive (≤5mm) and pedunculated polyps.
- Lesions suspected of harboring deep submucosal invasion.
- Patients who decline to participate or are unable to provide informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Conventional resection Standard polypectomy All eligible lesion identified in a patient will be resected by the conventional (gas distended colon) resection techniques. Excluded lesions will be resected by standard polypectomy. Underwater resection Standard polypectomy All eligible lesion identified in a patient will be resected by the underwater technique. Excluded lesions will be resected by standard polypectomy. Underwater resection Underwater resection All eligible lesion identified in a patient will be resected by the underwater technique. Excluded lesions will be resected by standard polypectomy. Conventional resection Conventional (gas distended colon) resection All eligible lesion identified in a patient will be resected by the conventional (gas distended colon) resection techniques. Excluded lesions will be resected by standard polypectomy.
- Primary Outcome Measures
Name Time Method Incomplete resection rate (histologic) 24 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sacramento VA Medical Center (VANCHCS)
🇺🇸Mather, California, United States